Primary results from a new clinical trial show that a discrete subset of patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) demonstrated especially ...

We introduce CIBERSORT, a method for characterizing cell composition of complex tissues from their gene expression profiles. When applied to enumeration of hematopoietic subsets in RNA mixtures from ...

Researchers at the Baylor College of Medicine and the University of Michigan Medical School have conducted a study showing that a specific subset of immune B cells delays the onset of type 1 diabetes ...

Scientists at the Baylor College of Medicine and the University of Michigan Medical School reported that a subset of immune B cells, known as CD19+IgM+ B cells, can delay the onset of type 1 diabetes ...

A recently described T cell subset may have a central role in the development of type 1 diabetes, research suggests. These so called follicular T helper cells were found to be increased at the onset ...

Triolex® Demonstrates Evidence of Anti-Inflammatory Activity in a Phase IIa Clinical Trial in a Subset of Type 2 Diabetes Mellitus Patients San Diego, CA - May 10, 2010 - Harbor Biosciences ...

Many nonparametric regression procedures are based on "subset selection": they choose a subset of carriers from a large or even infinite set, and then determine the coefficients of the chosen carriers ...

Primary results from a new clinical trial show that patients with type 1 diabetes treated with the monoclonal antibody teplizumab (MacroGenics, Inc.) exhibit greater preservation of C-peptide, a ...